Look how SP rose between late september 2011 and end of March 2012. Gained almost 7 fold peaking at $2.88. Hence, some posters forecasts of $1.40-1.50 are (IMO) not unrealistic.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025